First-Line Treatment of Metastatic Renal Cell Carcinoma
This video reviews the first-line treatment of metastatic renal cell carcinoma, including for those patients who are ineligible for interleukin-2.
In this video, Neeraj Agarwal, MD, of the University of Utah Huntsman Cancer Institute, reviews the first-line treatment of metastatic renal cell carcinoma, including for those patients who are ineligible for treatment with high-dose interleukin-2.
Agarwal spoke on this topic at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
